GPCM
ACHV icon

Granite Point Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Granite Point Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,631
Closed -$45K – 92
2022
Q3 		$45K Hold
13,631
– – 0.02% 95
2022
Q2 		$67K Buy
+13,631
New +$92.5K 0.02% 98

Other funds holding ACHV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Granite Point Capital Management's ACHV Position: Q4 2022 in Review

Granite Point Capital Management sold out of Achieve Life Sciences (ACHV) in Q4 2022, closing a stake of 13,631 shares — an estimated $45K sold.

Granite Point Capital Management first reported a position in ACHV in Q2 2022 and held it in 2 quarters. The position peaked at $67K in Q2 2022. 28 funds tracked by Wall St. Rank hold ACHV as of Q4 2022.

  • Granite Point Capital Management reported no remaining Achieve Life Sciences position as of Q4 2022 after selling out during the quarter.
  • Granite Point Capital Management sold 13,631 Achieve Life Sciences shares in Q4 2022, an estimated $45K.
  • Granite Point Capital Management first reported a position in Achieve Life Sciences in Q2 2022 and held it in 2 quarters.
  • Granite Point Capital Management's Achieve Life Sciences position peaked at $67K in Q2 2022.
  • 28 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2022.

Based on Granite Point Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.